日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Proteomics-Based Assessment of Inflammation Signatures in Endotoxemia

基于蛋白质组学的内毒血症炎症特征评估

Sean A Burnap, Ursula Mayr, Manu Shankar-Hari, Friederike Cuello, Mark R Thomas, Ajay M Shah, Ian Sabroe, Robert F Storey, Manuel Mayr

Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel Pharmacogenomics

支架血栓中 CYP2C19 的下一代测序:对氯吡格雷药物基因组学的启示

Joel A Morales-Rosado, Kashish Goel, Lingxin Zhang, Axel Åkerblom, Saurabh Baheti, John L Black, Niclas Eriksson, Lars Wallentin, Stefan James, Robert F Storey, Shaun G Goodman, Gregory D Jenkins, Bruce W Eckloff, Suzette J Bielinski, Hugues Sicotte, Stephen Johnson, Veronique L Roger, Liewei Wang, 

Circulating MicroRNA Levels Indicate Platelet and Leukocyte Activation in Endotoxemia Despite Platelet P2Y12 Inhibition

尽管血小板 P2Y12 受到抑制,循环 microRNA 水平仍表明内毒血症中的血小板和白细胞被激活

Aitana Braza-Boïls, Temo Barwari, Clemens Gutmann, Mark R Thomas, Heather M Judge, Abhishek Joshi, Raimund Pechlaner, Manu Shankar-Hari, Ramzi A Ajjan, Ian Sabroe, Robert F Storey, Manuel Mayr

Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome

在急性冠状动脉综合征的双重抗血小板治疗期间,每日两次服用极低剂量阿司匹林可维持血小板抑制并改善止血

William A E Parker, Rachel C Orme, Jessica Hanson, Hannah M Stokes, Claire M Bridge, Patricia A Shaw, Wael Sumaya, Kirstie Thorneycroft, Giovanna Petrucci, Benedetta Porro, Heather M Judge, Ramzi A Ajjan, Bianca Rocca, Robert F Storey

Inhibitory mechanisms of very low-dose rivaroxaban in non-ST-elevation myocardial infarction

极低剂量利伐沙班对非ST段抬高型心肌梗死的抑制机制

Oliver Borst, Patrick Münzer, Nada Alnaggar, Sascha Geue, Roland Tegtmeyer, Dominik Rath, Michal Droppa, Peter Seizer, Stefan Heitmeier, Johan W M Heemskerk, Lisa K Jennings, Robert F Storey, Dominick J Angiolillo, Bianca Rocca, Henri Spronk, Hugo Ten Cate, Meinrad Gawaz, Tobias Geisler

Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial

骨保护素与急性冠状动脉综合征患者的大出血有关,但与心血管结果无关:来自 PLATO(血小板抑制和患者结果)试验的见解

Thor Ueland, Axel Åkerblom, Tatevik Ghukasyan, Annika E Michelsen, Pål Aukrust, Richard C Becker, Maria Bertilsson, Anders Himmelmann, Stefan K James, Agneta Siegbahn, Robert F Storey, Frederic Kontny, Lars Wallentin; PLATO (Platelet Inhibition and Patient Outcomes) Trial Investigators

Ticagrelor potentiates adenosine-induced stimulation of neutrophil chemotaxis and phagocytosis

替格瑞洛增强腺苷诱导的中性粒细胞趋化和吞噬作用

Khalaf F Alsharif, Mark R Thomas, Heather M Judge, Haroon Khan, Lynne R Prince, Ian Sabroe, Victoria C Ridger, Robert F Storey

The active metabolite of prasugrel effectively blocks the platelet P2Y12 receptor and inhibits procoagulant and pro-inflammatory platelet responses

普拉格雷的活性代谢物有效阻断血小板 P2Y12 受体,抑制促凝和促炎血小板反应

Heather M Judge, Robert J Buckland, Atsuhiro Sugidachi, Joseph A Jakubowski, Robert F Storey